Jacobs Reports Strong Fiscal Second Quarter 2025 Results

In This Article:

Backlog Grows by 20% Year-Over-Year with TTM Book-to-Bill Ratio of 1.3x

Repurchased $351 Million of Jacobs Shares During Q2 and $552 Million in First Half of FY25

Exited Company's Retained Stake in AMTM and Announced May 30th Distribution of Remaining Shares

Reaffirming FY 2025 Guidance

DALLAS, May 6, 2025 /PRNewswire/ -- Jacobs Solutions Inc. (NYSE: J) today announced its financial results for the fiscal second quarter ended March 28, 2025.

Q2 2025 Highlights1:

  • Gross revenue of $2.9 billion grew 2.2% y/y; adjusted net revenue2 up 3.1% y/y

  • Revenue and profit adversely impacted by a reserve following an interim ruling against a consolidated JV in Q2 2025

  • GAAP net earnings of $11.2 million; adjusted EBITDA2 of $287 million

  • Recorded $109.5 million in mark-to-market losses on Amentum (AMTM) investment, reducing Q2 2025 GAAP net income and EPS

  • EPS of $0.10; adjusted EPS2 of $1.43

  • Backlog of $22.2 billion, up 20.0% y/y; Q2 book-to-bill 1.1x (1.3x TTM)

Jacobs' Chair and CEO Bob Pragada commented, "We ended the first half of FY25 with solid performance across our business, led by strong Life Sciences, Transportation and Energy & Power revenue growth within Infrastructure & Advanced Facilities (I&AF). Additionally, we saw strong results in PA Consulting, with revenue growth increasing to 5% in the second quarter, driving 12% operating profit growth for the segment. As we look ahead to the second half of the fiscal year, we continue to see tailwinds in both segments from robust bookings as well as a healthy pipeline of opportunities across our end markets. Based on this performance, we are reaffirming our full-year fiscal 2025 guidance."

Jacobs' CFO Venk Nathamuni added, "We delivered strong second quarter results. We saw sequential improvement in GAAP EPS and net margin, with good year-over-year growth in adjusted EBITDA, adjusted EBITDA margin and adjusted EPS. We are pleased we were able to offset the bottom line impact from an adverse interim ruling against a consolidated JV in which the Company holds a 50% interest. This demonstrates our strong core operating performance during Q2 2025 and puts us on track to achieve our full-year targets.

"We returned record amounts of capital back to shareholders in the first half of the year, repurchasing $351 million of our shares in Q2 2025 and $552 million in H1 2025, demonstrating our commitment to capital returns. We also retired $312 million in debt via an equity for debt exchange using our stake in AMTM, and refinanced approximately $700 million of existing debt at a lower interest rate, putting our balance sheet in excellent shape exiting Q2 2025. Subsequent to Q2 2025 close, we successfully completed a key milestone in connection with the separation of the former CMS and C&I businesses by finalizing the post-closing adjustment to working capital, enabling incremental debt reduction during Q3 2025, and receiving Board approval to distribute the remaining Amentum shares to our shareholders on May 30th."